Clinical Trial Update: 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating 68-Ga PSMA-11 PET/MRI and 68-Ga RM2 PET/MRI for monitoring prostate cancer response to HIFU therapy; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68-Ga-PSMA-11
• 68-Ga-RM2 (68-Ga-RM2)

Snippet

Sponsor: Andrei Iagaru | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-01-30